Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mike H. de Jager"'
Autor:
Johanna M. W. Hazes, Wai-Kwan Lam-Tse, Angelique E. A. M. Weel, N H A M Denissen, Pascal H P de Jong, Jolanda J. Luime, T.M. Kuijper, Andreas H. Gerards, Mike H. de Jager, Elise van Mulligen, Annette H M van der Helm-van Mil
Publikováno v:
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, 79(12), 1550-1556. BMJ PUBLISHING GROUP
Annals of the Rheumatic Diseases, 79(12), 1550-1556. BMJ Publishing Group
Annals of the Rheumatic Diseases, 79(12), 1550-1556. BMJ PUBLISHING GROUP
Annals of the Rheumatic Diseases, 79(12), 1550-1556. BMJ Publishing Group
ObjectiveThe aim of the current study was to evaluate the 2-year cost-utility ratio between tapering conventional synthetic disease-modifying antirheumatic drugs (csDMARD) first followed by the tumour necrosis factor (TNF)-inhibitor, or vice versa, i
Autor:
Jos Hendrikx, Steven Teerenstra, Nanno Swen, Johannes W G Jacobs, Ramon Voorneman, M. Efde, Andreas H. Gerards, Piet L. C. M. van Riel, Yvonne P M Goekoop-Ruiterman, Marjan Ghiti Moghadam, Jolanda J. Luime, Cees J. Haagsma, Mike H. de Jager, T.L.Th.A. Jansen, Femke B. G. Lamers-Karnebeek, Emma M van Rooyen, David F Ten Cate, N.M. Basoski
Publikováno v:
Rheumatology, 56, 9, pp. 1560-1565
Rheumatology, 56, 1560-1565
Rheumatology, 56(9), 1560-1565. Oxford University Press
Rheumatology, 56, 1560-1565
Rheumatology, 56(9), 1560-1565. Oxford University Press
Item does not contain fulltext Objective: Ultrasonography (US) can be used for treatment decisions in RA patients. This study investigated the added value of US to clinical variables in predicting flare in RA patients with longstanding low disease ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ca62bc25aa81ea7160cc1845a02c2c0
https://doi.org/10.1093/rheumatology/kex184
https://doi.org/10.1093/rheumatology/kex184
Autor:
Jolanda J. Luime, Andreas H. Gerards, Peter B J de Sonnaville, Mike H. de Jager, Pascal H P de Jong, B. Grillet, Leander R. Buisman, Derkjen van Zeben, Peter A H M van der Lubbe, Johanna M. W. Hazes, Angelique E. A. M. Weel, Pieternella J. Barendregt
Publikováno v:
Rheumatology, 55(12), 2138-2147. Oxford University Press
OBJECTIVE: To evaluate direct and indirect costs per quality adjusted life year (QALY) for different initial treatment strategies in very early RA.METHODS: The 1-year data of the treatment in the Rotterdam Early Arthritis Cohort trial were used. Pati
Autor:
Nanno Swen, Johanna M. W. Hazes, Johannes W G Jacobs, David F Ten Cate, N.M. Basoski, Jolanda J. Luime, Cees J Haagsma, Andreas H. Gerards, Mike H. de Jager
Publikováno v:
Arthritis Research & Therapy, 15(1). BioMed Central Ltd.
Arthritis Research & Therapy
Arthritis Research & Therapy
Introduction: Ultrasonography (US) might have an added value to clinical examination in diagnosing early rheumatoid arthritis (RA) and assessing remission of RA. We aimed to clarify the added value of US in RA in these situations performing a systema
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e21aec4eb9463fdfcf0f6d0797b244db
https://pure.eur.nl/en/publications/545715ae-4a54-42cb-9283-614706d58737
https://pure.eur.nl/en/publications/545715ae-4a54-42cb-9283-614706d58737
Autor:
Angelique E. A. M. Weel, Jolanda J. Luime, Peter A. van der Lubbe, Derkjen van Zeben, Mike H. de Jager, J.M. Hazes, Pascal H. P. de Jong, Peter B J de Sonnaville
Publikováno v:
Rheumatology, 51(7), 1269-1277. Oxford University Press
OBJECTIVE: To evaluate the therapeutic and economic consequences of various disease activity indices (DAIs) in RA according to 1987 and 2010 criteria.METHODS: Data on disease activity states from all sustained visits were assessed from all patients w
Autor:
K. Huub Han, Ben A. C. Dijkmans, P E H Seys, I. Speyer, B. Grillet, Pit J S M Kerstens, Mike H. de Jager, Ferdinand C. Breedveld, Cornelia F Allaart, Jeska K de Vries-Bouwstra, Peter A H M van der Lubbe, Yvonne P M Goekoop-Ruiterman
Publikováno v:
Annals of the rheumatic diseases. 66(9)
Objectives: To determine treatment preferences among patients with recent onset rheumatoid arthritis participating in a randomized controlled trial comparing four therapeutic strategies. Methods: A questionnaire was sent to all 508 participants of th